Abstract

Endemic mycoses such as histoplasmosis, coccidioidomycosis, blastomycosis, paracoccidioidomycosis, and talaromycosis are well-known causes of focal and systemic disease within specific geographic areas of known endemicity. However, over the past few decades, there have been increasingly frequent reports of infections due to endemic fungi in areas previously thought to be “non-endemic.” There are numerous potential reasons for this shift such as increased use of immune suppressive medications, improved diagnostic tests, increased disease recognition, and global factors such as migration, increased travel, and climate change. Regardless of the causes, it has become evident that our previous understanding of endemic regions for these fungal diseases needs to evolve. The epidemiology of the newly described Emergomyces is incomplete; our understanding of it continues to evolve. This review will focus on the evidence underlying the established areas of endemicity for these mycoses as well as new data and reports from medical literature that support the re-thinking these geographic boundaries. Updating the endemic fungi maps would inform clinical practice and global surveillance of these diseases.

Details

Title
Re-drawing the Maps for Endemic Mycoses
Author
Nida, Ashraf 1 ; Kubat, Ryan C 1 ; Poplin, Victoria 2 ; Adenis, Antoine A 3 ; Denning, David W 4 ; Wright, Laura 5 ; McCotter Orion 6 ; Schwartz, Ilan S 7 ; Jackson, Brendan R 6 ; Chiller Tom 6 ; Bahr, Nathan C 1   VIAFID ORCID Logo 

 University of Kansas, Division of Infectious Diseases, Department of Internal Medicine, Kansas City, USA (GRID:grid.266515.3) (ISNI:0000 0001 2106 0692) 
 University of Kansas, Department of Internal Medicine, Kansas City, USA (GRID:grid.266515.3) (ISNI:0000 0001 2106 0692) 
 Centre Hospitalier de Cayenne, Centre d’Investigation Clinique Antilles-Guyane, Inserm 1424, Cayenne, French Guiana (GRID:grid.440366.3) (ISNI:0000 0004 0630 1955) 
 University of Manchester, Manchester Academic Health Science Centre, Faculty of Biology, Medicine, and Health, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
 Centers for Disease Control and Prevention, Geographic Research Analysis and Services Program, Division of Toxicology and Human Health Services, Atlanta, USA (GRID:grid.416738.f) (ISNI:0000 0001 2163 0069) 
 Mycotic Branch, Centers for Disease Control and Prevention, Atlanta, USA (GRID:grid.416738.f) (ISNI:0000 0001 2163 0069) 
 University of Alberta, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine & Dentistry, Edmonton, Canada (GRID:grid.17089.37) 
Pages
843-865
Publication year
2020
Publication date
Oct 2020
Publisher
Springer Nature B.V.
ISSN
0301486X
e-ISSN
15730832
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471805654
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.